pathopharmacological Ischemic Heart Disease

1. _____ Introduction to disease process

2. _____Pathophysiology discussed with in-text citation(s)

3. _____Standard of Practice with in-text citation(s) if appropriate

4. _____Pharmacologic treatments with in-text citation(s)

5. _____ Pharmacologic impact on my community with in-text citation(s) if applicable

6. _____Clinical guidelines for disease assessment with in-text citation(s)

7. _____ Clinical guidelines for disease diagnosis with in-text citation(s)

8. _____Clinical guidelines for disease related patient education with in-text citation(s)

9. _____ Comparison of care management with State OR National practices [circle one] with in-text citation(s)

10. Characteristics of/resources for a patient who manages the disease well with in-text citation(s)

_____ Access to care

_____ Treatment options

_____ Life Expectancy

_____ Outcomes

11. ____ Disparities in care management on the National level with in-text citation(s)

12. ____ Disparities in care management on the International level with in-text citation(s)

13. ____ 3 Factors that facilitate to patient managing the disease well [in-text citation(s) if applicable]

14. ____ 3 Factors discussed above that when absent lead to unmanaged disease process [in-text citation(s) if applicable]

15. ____ Characteristics of a patient who does not manage the disease well

16. Discussion of how the disease affects each of the following – IN YOUR COMMUNITY [with in-text citation(s) where applicable] From Diagnosis to Treatment

_____ Patients

_____ Families

_____ Populations

17. Costs associated with the disease process for each of the following [with in-text citation(s) where applicable]

_____ Patients

_____ Families

_____ Populations

18. ____ Discuss how you will promote best practices in your current practice setting

19. Three Strategies to IMPLEMENT best practices [with in-text citation(s) where applicable]

_____ Strategy 1 is . . . __________________________________________________

_____ Strategy 2 is . . . __________________________________________________

_____ Strategy 3 is . . . __________________________________________________

20. Three Methods to EVALUATE the three implementation Strategies that you listed above [with in-text citation(s) where applicable]

_____Evaluate Strategy 1 . . . ____________________________________________

_____ Evaluate Strategy 2 . . . ____________________________________________

_____ Evaluate Strategy 3 . . . ____________________________________________

NOTE: Adequate detail would likely be comprised of at least a full, narrative paragraph. Remember that a paragraph is a minimum of 3 to 6 sentences.